000 05956cam a2200553 i 4500
999 _c92268
_d92268
005 20250829111327.0
006 m o d
007 cr cnu---unuuu
008 250829t20222022njum ob u001 0 eng
020 _a9781119785002
020 _a9781119785033
_qelectronic book
020 _a1119785030
_qelectronic book
020 _a9781119785019
_qelectronic book
020 _a1119785014
_qelectronic book
020 _a9781119785026
_qelectronic book
020 _a1119785022
_qelectronic book
020 _z9781119785002
_qpaperback
035 _a(OCoLC)1327844146
040 _aDLC
_beng
_erda
_cDLC
_dYDX
_dDG1
041 _aeng
042 _apcc
050 0 4 _aRC661.I6
_bD53 2022
060 0 0 _aWK 825
082 0 0 _a616.4/62061
_223/eng/20220608
245 0 0 _aDiabetes drug notes /
_cedited by Miles Fisher, Gerard A. McKay, Andrea Llano.
264 1 _aHoboken, NJ :
_bWiley-Blackwell,
_c2022.
264 4 _c©2022.
300 _a1 online resource (xxiv, 368 pages) :
_billustrations (some color)
336 _atext
_btxt
_2rdacontent.
337 _acomputer
_bc
_2rdamedia.
338 _aonline resource
_bcr
_2rdacarrier.
340 _2rdacc
_0http://rdaregistry.info/termList/RDAColourContent/1003.
504 _aIncludes bibliographical references and index.
505 0 _aClinical pharmacology of antidiabetic drugs / Andrea Llano, Gerry McKay, and Ken Paterson -- Metformin / Joseph G. Timmons and James G. Boyle -- Sulfonylureas and meglitinides -- Joseph G. Timmons and James G. Boyle -- DPP-4 inhibitors / Sharon Mackin and Gemma Currie -- SGLT2 inhibitors / Miles Fisher, Andrea Llano, and Gerry McKay -- GLP-1 receptor agonists / Catherine Russell and John R. Petrie -- Animal and human insulin / Ken Paterson -- Short-ccting insulin analogues / Kate Hughes and Gerry McKay -- Long-acting Insulin Analogues / Robert Lindsay -- Devices / David Carty -- Acarbose and alpha glucosidase inhibitors / Miles Fisher -- Glitazones and glitazars / Miles Fisher -- Other antidiabetic drugs / Maroria Oroko, Andrea Llano, and Miles Fisher -- Future antidiabetic drugs / Emma Johns and Miles Fisher -- Guidelines / Miles Fisher and Russell Drummond -- Prescribing antidiabetic drugs / Andrea Llano, Gerry McKay, Frances McManus, Catriona McClements, Joyce McKenzie, and Deborah Morrison.
520 _a"At Glasgow Royal Infirmary historically diabetes and clinical pharmacology were linked with specialists in each discipline contributing to one of the medical units in the provision of general medical care to the inhabitants of the east of Glasgow whilst delivering specialist expertise. A few miles north of the Royal Infirmary, Stobhill Hospital in its prime had physicians delivering care who were also delivering academic excellence in the Department of Materia Medica at the University of Glasgow. In 2011 the two hospitals in the northeast of Glasgow merged to provide in patient care on one site and in doing so brought together the prospect of having a combined Department of Diabetes, Endocrinology and Clinical Pharmacology. In addition to having a long-standing reputation for recruiting patients to commercial studies, the Royal Infirmary has strong links with the University of Glasgow, with senior academics continuing to provide both general and specialist patient care, and the University of Strathclyde Institute of Pharmacy and Biomedical Sciences, specifically around training independent pharmacy prescribers. Education and training have been hallmarks of the department and in 2008 a series of Drug Notes was established for Practical Diabetes, covering drugs used in those with diabetes but not necessarily ones for lowering blood glucose, encouraging trainees to be first authors. The series is still going, suggesting that an understanding of drugs is an essential part of being a healthcare provider with an interest in diabetes. Antidiabetic drugs were covered in two separate series for the British Journal of Cardiology, again with trainees aspiring to be specialists in diabetes and endocrinology being first authors and to consider clinical pharmacology as a key knowledge skill"--
_cProvided by publisher.
545 0 _aAbout the Author Prof. Miles Fisher is a former Consultant Physician, Department of Diabetes, Endocrinology and Clinical Pharmacology, Glasgow Royal Infirmary, and an Honorary Professor at the University of Glasgow, UK. Prof. Gerard A. McKay is a Consultant Physician, Department of Diabetes, Endocrinology and Clinical Pharmacology, Glasgow Royal Infirmary, an Honorary Clinical Associate Professor, University of Glasgow, as well as a Visiting Professor at the University of Strathclyde, UK. Dr Andrea Llano is a Consultant Physician, Department of Diabetes, Endocrinology and Clinical Pharmacology, Glasgow Royal Infirmary, and an Honorary Clinical Lecturer, University of Glasgow, UK.
650 0 _aDiabetes
_0http://id.loc.gov/authorities/subjects/sh85037456
_xChemotherapy.
_0http://id.loc.gov/authorities/subjects/sh99004980.
650 0 _aDrugs.
_0http://id.loc.gov/authorities/subjects/sh85039719.
650 1 2 _aHypoglycemic Agents
_xpharmacology.
_0https://id.nlm.nih.gov/mesh/D007004Q000494.
650 2 2 _aGlycoside Hydrolase Inhibitors
_xpharmacology.
_0https://id.nlm.nih.gov/mesh/D065089Q000494.
650 2 2 _aInsulins
_xpharmacology.
_0https://id.nlm.nih.gov/mesh/D061385Q000494.
650 2 2 _aDiabetes Mellitus
_xdrug therapy.
_0https://id.nlm.nih.gov/mesh/D003920Q000188.
655 4 _aElectronic books.
700 1 _aFisher, Miles,
_0http://id.loc.gov/authorities/names/nb2003011090
_eeditor.
700 1 _aMcKay, Gerard A.,
_0http://id.loc.gov/authorities/names/n2010181936
_eeditor.
700 1 _aLlano, Andrea,
_0http://id.loc.gov/authorities/names/n2022182238
_eeditor.
856 _uhttps://onlinelibrary.wiley.com/doi/book/10.1002/9781119785033
_yFull text is available at Wiley Online Library Click here to view
942 _2ddc
_cER